Merck Life Science Nantong Phase II Solvent Production Project - Group Comprehensive Inspection


Merck Life Science Nantong Phase II Solvent Production Project - Group Comprehensive Inspection

On July 3, the Group's inspection team visited the Merck Life Science Nantong Phase II Solvent Production Project, constructed by Maosheng Branch Company, for inspection and guidance. After listening to the report, the Group's inspection team conducted a comprehensive inspection of the project entity, on-site management, project data, and the real-name system for laborers, and engaged in in-depth exchanges with the project department. Finally, the head of the inspection team and general manager, Zhang Jian, summarized the findings, fully affirming the project team's high management level and outstanding project highlights. He also expressed hope that the branch company and the Group would continue to maintain communication and exchanges, consolidate their advantages in the foreign-invested industrial sector, and make greater contributions to the high-quality development of the Group!

Recommended news


Group Company Wins Multiple 2025 Safety Management Awards

On March 13, at the contractor safety conference held at Dow’s Zhangjiagang site, the Group was recognized as the “2025 Best Safety Performance Unit” for its outstanding safety management system and robust on-site execution capabilities, setting it apart from numerous other contractors. This prestigious award not only represents the client’s full endorsement of Jiangsu Qian’an’s long-standing commitment to the “safety first” principle, but also underscores the company’s exceptional ability to continuously enhance its safety management standards in collaboration with internationally renowned enterprises. In addition, Guo Ronggao, a member of the company’s workforce, was honored with the title of “2025 Best Individual in Safety Performance” for his diligent safety management, strict adherence to safety regulations, and proactive demonstration of exemplary leadership.


The Group Company has successfully won the bid for the Roche (Shanghai) Biopharmaceutical Production Base Project.

Recently, good news came from the Shanghai market: the Group has successfully won the bid for the Roche (Shanghai) Biopharmaceutical Production Base Project (Phase I), with a contract value exceeding 120 million yuan.


The Group Company’s comprehensive post‑Spring Festival training for 2026 has successfully concluded.

Spring ushers in the new year—action comes first in all matters. From February 25 to 28, the Group organized comprehensive post‑Spring Festival training for 2026. This training adopted a blended model of “online classes + on-site instruction,” aiming to help all employees quickly refocus and get back to work with full energy, embarking on the journey of the new year with a spirited,全力以赴 (full‑power) work ethic.


The Group Company organized a symposium on delegated work for the year 2025.

On the afternoon of February 28, the Group held a symposium on delegated work for 2025 in Conference Room 402 of Qian’an Building. With the theme “Delegation Comes with Responsibility, Performance Brings Results,” the meeting aimed to comprehensively review the achievements of delegated work in 2025, distill best practices and lessons learned, solicit opinions and suggestions, and further strengthen collaborative efforts.


The Group Company Held the 8th Meeting of the 3rd Shareholders’ Assembly and the Annual Work Conference.

On the afternoon of March 2, the 8th Session of the 3rd Shareholders’ Meeting and the Annual Work Conference of the Group Company were successfully held in the Conference Hall on the 4th floor of Qian’an Building. Zhou Bing, Director of the Housing and Urban–Rural Development Bureau of Qidong City, and Zhang Xiaofeng, Deputy Director, attended the meeting by invitation, along with nearly one hundred participants, including company shareholders, heads of the Group Headquarters, regional companies, directly affiliated units, and branch offices. The meeting was chaired by General Manager Zhang Jian.


Interpreting the Key Contents of the Safety Technical Specifications for Work in Confined Spaces

On October 31, 2025, the State Administration for Market Regulation and the National Standardization Administration Committee released the “Safety Technical Code for Work in Confined Spaces” (GB46768-2025), which came into effect on May 1, 2026. The core content includes safety management, pre‑work safety technical requirements, in‑work safety technical requirements, post‑work safety technical requirements, and verification methods.